Faget Comments on New FDA Guidance

26 September 2019 Mobi Health News News

Special Counsel Kyle Faget  was quoted in a Mobi Health News article, “FDA releases revised draft guidance on CDS software, final guidelines on ‘device’ definitions for software such as wellness apps,” about new guidance designed to bring the agency’s efforts into compliance with provisions of the 21st Century Cures Act.

Faget said regulatory uncertainty stifles innovation either by discouraging innovators from entering a field where the regulatory uncertainty creates an unnecessary barrier to entry or by delaying commercialization as innovators seek clarification regarding the regulatory status of their software. “Now that these guidances are available and in final form, digital health developers will have to get to work operationalizing the principles articulated in the guidances,” she said.

People

Related Services

Insights

Will Other Tech Companies Join Microsoft in Honoring CCPA Across the U.S.?
18 November 2019
Internet, IT & e-Discovery Blog
Get Off My Lawn! Employers Gain Expanded Rights to Keep Unions Away from Their Property
18 November 2019
Labor & Employment Law Perspectives
Debunking Conventional Labor and Employment Wisdom
18 November 2019
Labor & Employment Law Perspectives
Racing to Innovate: The OESA’s 2019 Industry Outlook Panel
14 November 2019
Dashboard Insights
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call